Health Notices




916 NEW ZEALAND GAZETTE, No. 35 24 MARCH 2011

Health

Health and Disability Services (Safety) Act 2001

Cancellation of Designation of Auditing Agency

Pursuant to section 37(1)(c) of the Health and Disability Services (Safety) Act 2001 ("the Act"), the Director-General of Health cancels the designation of

Enhancing Quality Services Limited
to audit the provision of health and disability services under the Act.

This cancellation takes effect from 17 September 2010.

Dated at Wellington this 9th day of September 2010.

ANDREW BRIDGMAN, Acting Director-General of Health.

go1885

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Sativex

Active Ingredients:
Cannabidiol 25mg/mL equivalent to cannabis sativa extract 35mg–42mg
Tetrahydrocannabinol 27mg/mL equivalent to cannabis sativa extract 38mg–44mg

Dosage Form: Oral spray

New Zealand Sponsor: Health Support Limited

Manufacturer: GW Pharma Limited, Kent, United Kingdom

Dated this 17th day of March 2011.

PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1823

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Advil (General Sale)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Liquid filled capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Catalent Australia Pty Limited, Braeside, Australia

Product: Advil (Pharmacy Only)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Liquid filled capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Catalent Australia Pty Limited, Braeside, Australia

Product: Finasteride
Active Ingredient: Finasteride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Dr Reddy’s Laboratories Limited, Bachupally, India

Dated this 17th day of March 2011.

PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1822



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 35





✨ LLM interpretation of page content

🏥 Cancellation of Designation of Auditing Agency

🏥 Health & Social Welfare
9 September 2010
Health and Disability Services, Auditing Agency, Cancellation
  • ANDREW BRIDGMAN, Acting Director-General of Health

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
17 March 2011
Medicines Act, New Medicine, Sativex, Cannabidiol, Tetrahydrocannabinol
  • PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
17 March 2011
Medicines Act, New Medicines, Advil, Ibuprofen, Finasteride
  • PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health